{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:57:13Z","timestamp":1788368233436,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01-DK084195"],"award-info":[{"award-number":["R01-DK084195"]}]},{"name":"NIH","award":["R01-HL109582"],"award-info":[{"award-number":["R01-HL109582"]}]},{"name":"NIH","award":["K01-HL096413"],"award-info":[{"award-number":["K01-HL096413"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["11GRN7660018"],"award-info":[{"award-number":["11GRN7660018"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Florida JEK Bridge Award","award":["2KB03"],"award-info":[{"award-number":["2KB03"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bbagen.2013.02.018","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T14:17:16Z","timestamp":1361888236000},"page":"3696-3710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Small molecule agonists of integrin CD11b\/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury"],"prefix":"10.1016","volume":"1830","author":[{"given":"Mohd Hafeez","family":"Faridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet M.","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Camilo","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto I.","family":"Vazquez-Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2013.02.018_bb0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI7811","article-title":"Decreased neointimal formation in Mac-1(\u2212\/\u2212) mice reveals a role for inflammation in vascular repair after angioplasty","volume":"105","author":"Simon","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI110955","article-title":"Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte\u2013granulocyte membrane glycoprotein (Mol)","volume":"72","author":"Arnaout","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0020","first-page":"105","article-title":"Functional analysis of the beta 2 integrins","volume":"129","author":"Li","year":"1999","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0025","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1074\/jbc.271.27.15858","article-title":"Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor","volume":"271","author":"Rieu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1189\/jlb.0804460","article-title":"Targeting leukocyte integrins in human diseases","volume":"77","author":"Yonekawa","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd1174","article-title":"Therapeutic antagonists and conformational regulation of integrin function","volume":"2","author":"Shimaoka","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0040","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1097\/00003246-200205001-00007","article-title":"Leukocyte\u2013endothelial interactions: clinical trials of anti-adhesion therapy","volume":"30","author":"Harlan","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0045","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd3266","article-title":"Integrins as therapeutic targets: lessons and opportunities","volume":"9","author":"Cox","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/78412","article-title":"CD18 trials disappoint again","volume":"18","author":"Dove","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrrheum.2009.142","article-title":"Therapy: targeted but not trouble-free: efalizumab and PML","volume":"5","author":"Molloy","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0060","doi-asserted-by":"crossref","first-page":"ra57","DOI":"10.1126\/scisignal.2001811","article-title":"Small molecule-mediated activation of the integrin CD11b\/CD18 reduces inflammatory disease","volume":"4","author":"Maiguel","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-065X.2002.18612.x","article-title":"Integrin structure: new twists and turns in dynamic cell adhesion","volume":"186","author":"Arnaout","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0070","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.4049\/jimmunol.154.10.5452","article-title":"Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules","volume":"154","author":"Stockl","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0075","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.4049\/jimmunol.166.9.5629","article-title":"Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation","volume":"166","author":"Lu","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0080","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4049\/jimmunol.155.2.854","article-title":"Activation of lymphocyte function-associated molecule-1 (CD11a\/CD18) and Mac-1 (CD11b\/CD18) mimicked by an antibody directed against CD18","volume":"155","author":"Petruzzelli","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0085","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/j.1460-2075.1989.tb08552.x","article-title":"Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits","volume":"8","author":"Dransfield","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0090","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/eji.1830230925","article-title":"KIM185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion","volume":"23","author":"Andrew","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/15419069509081292","article-title":"KIM127, an antibody that promotes adhesion, maps to a region of CD18 that includes cysteine-rich repeats","volume":"3","author":"Stephens","year":"1995","journal-title":"Cell Adhes. Commun."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1189\/jlb.68.5.641","article-title":"AlphaMbeta2 (CD11b\/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive","volume":"68","author":"Orchekowski","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0105","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.167.11.6113","article-title":"CD18 activation epitopes induced by leukocyte activation","volume":"167","author":"Beals","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0110","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1073\/pnas.97.10.5231","article-title":"NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding","volume":"97","author":"Huth","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0115","doi-asserted-by":"crossref","first-page":"18345","DOI":"10.1073\/pnas.0909301106","article-title":"Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/eji.1830250302","article-title":"Antibodies that activate beta 2 integrins can generate different ligand binding states","volume":"25","author":"Ortlepp","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1084\/jem.158.2.586","article-title":"Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1","volume":"158","author":"Sanchez-Madrid","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneph.2011.16","article-title":"Pathophysiology of ischemic acute kidney injury","volume":"7","author":"Sharfuddin","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0135","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2005-12-023044","article-title":"Active MAC-1 (CD11b\/CD18) on DCs inhibits full T-cell activation","volume":"109","author":"Varga","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2567.1999.00654.x","article-title":"Differential effects of anti-rat CD11b monoclonal antibodies on granulocyte adhesiveness","volume":"96","author":"Draskovic-Pavlovic","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0145","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.4049\/jimmunol.0900983","article-title":"Outside-in signal transmission by conformational changes in integrin Mac-1","volume":"183","author":"Lefort","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0150","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.4049\/jimmunol.181.5.3609","article-title":"Neutrophil apoptosis: selective regulation by different ligands of integrin alphaMbeta2","volume":"181","author":"Pluskota","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0155","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1083\/jcb.151.6.1305","article-title":"Differential roles for alpha(M)beta(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms","volume":"151","author":"Whitlock","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0160","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1073\/pnas.80.18.5699","article-title":"Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies","volume":"80","author":"Wright","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI3312","article-title":"A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1","volume":"103","author":"Hogg","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jlb.46.6.556","article-title":"Heterogeneity of macrophages in the rat evidenced by variability in determinants: two new anti-rat macrophage antibodies against a heterodimer of 160 and 95kd (CD11\/CD18)","volume":"46","author":"Damoiseaux","year":"1989","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0175","first-page":"239","article-title":"Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3","volume":"57","author":"Robinson","year":"1986","journal-title":"Immunology"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eji.1830090410","article-title":"Mac-1: a macrophage differentiation antigen identified by monoclonal antibody","volume":"9","author":"Springer","year":"1979","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1087057106299162","article-title":"A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b\/CD18","volume":"12","author":"Park","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0190","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood-2005-11-056689","article-title":"The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b\/CD18","volume":"109","author":"Gupta","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0195","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2008-12-195164","article-title":"The small Rho GTPase Cdc42 regulates neutrophil polarity via CD11b integrin signaling","volume":"114","author":"Szczur","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0200","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood-2003-01-0334","article-title":"New insights into the structural basis of integrin activation","volume":"102","author":"Xiong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2261-2-16","article-title":"A comparison of balloon injury models of endovascular lesions in rat arteries","volume":"2","author":"Gabeler","year":"2002","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0210","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1016\/j.bmcl.2009.10.077","article-title":"Identification of novel agonists of the integrin CD11b\/CD18","volume":"19","author":"Faridi","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2006.07.016","article-title":"Activation of leukocyte beta(2) integrins by conversion from bent to extended conformations","volume":"25","author":"Nishida","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0220","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.4049\/jimmunol.147.6.1891","article-title":"Occupancy of CD11b\/CD18 (Mac-1) divalent ion binding site(s) induces leukocyte adhesion","volume":"147","author":"Altieri","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.116.1.219","article-title":"Divalent cation regulation of the function of the leukocyte integrin LFA-1","volume":"116","author":"Dransfield","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0230","doi-asserted-by":"crossref","first-page":"38762","DOI":"10.1074\/jbc.C000563200","article-title":"An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain","volume":"275","author":"Xiong","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0240","doi-asserted-by":"crossref","first-page":"46764","DOI":"10.1074\/jbc.M407951200","article-title":"Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by X-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo","volume":"279","author":"Weitz-Schmidt","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6750-4-21","article-title":"A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods","volume":"4","author":"Yarrow","year":"2004","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0250","first-page":"177","article-title":"Cell migration into a wounded area in vitro","volume":"96","author":"Lampugnani","year":"1999","journal-title":"Meth. Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0255","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tcb.2005.09.002","article-title":"Inflammatory cells during wound repair: the good, the bad and the ugly","volume":"15","author":"Martin","year":"2005","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature06887","article-title":"Rapid leukocyte migration by integrin-independent flowing and squeezing","volume":"453","author":"Lammermann","year":"2008","journal-title":"Nature"},{"issue":"Pt 22","key":"10.1016\/j.bbagen.2013.02.018_bb0265","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1242\/jcs.112.22.4067","article-title":"Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck\/Fgr deficient macrophages","volume":"112","author":"Suen","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0270","doi-asserted-by":"crossref","first-page":"e4449","DOI":"10.1371\/journal.pone.0004449","article-title":"The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells","volume":"4","author":"Alghisi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0275","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2174\/1381612043384673","article-title":"Oral GPIIb\/IIIa antagonists: what went wrong?","volume":"10","author":"Cox","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0280","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood.V92.9.3240","article-title":"Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb\/IIIa (alphaIIbbeta3) inhibitors","volume":"92","author":"Peter","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0285","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.4049\/jimmunol.1102394","article-title":"Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b\/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug design","volume":"187","author":"Mahalingam","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0290","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2010-04-281154","article-title":"Closed headpiece of integrin alphaIIbbeta3 and its complex with an alphaIIbbeta3-specific antagonist that does not induce opening","volume":"116","author":"Zhu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.103.2.201","article-title":"Increased mortality with oral platelet glycoprotein IIb\/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0300","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1172\/JCI36745","article-title":"Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain","volume":"119","author":"Gao","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0305","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0310","doi-asserted-by":"crossref","first-page":"29468","DOI":"10.1074\/jbc.M204990200","article-title":"The small GTPase Rap1 is required for Mn(2+)- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion","volume":"277","author":"de Bruyn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0315","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1074\/jbc.M309778200","article-title":"Integrins and cytokines activate nuclear transcription factor-kappaB in human neutrophils","volume":"279","author":"Kettritz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0320","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1182\/blood.V97.10.2932","article-title":"Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB","volume":"97","author":"Rezzonico","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0325","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1096\/fasebj.13.13.1855","article-title":"A role for beta(2) integrins (CD11\/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response","volume":"13","author":"Walzog","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0330","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0335","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1074\/jbc.270.26.15719","article-title":"Dissociation of mitogen-activated protein kinase activation from the oxidative burst in differentiated HL-60 cells and human neutrophils","volume":"270","author":"Yu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0340","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1084\/jem.20041850","article-title":"Importance of integrin LFA-1 deactivation for the generation of immune responses","volume":"201","author":"Semmrich","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0345","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1172\/JCI31570","article-title":"Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut","volume":"117","author":"Park","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0350","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood-2009-08-237917","article-title":"Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes","volume":"115","author":"Park","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0355","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1126\/science.1084174","article-title":"Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins","volume":"301","author":"Kim","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0360","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.570838","article-title":"Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients","volume":"114","author":"Stroupe","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0365","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.hlc.2007.02.089","article-title":"Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents","volume":"16","author":"Ajani","year":"2007","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0370","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity","volume":"151","author":"Chen","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0375","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jacc.2010.05.009","article-title":"Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial","volume":"56","author":"Kaltoft","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0380","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/CIRCULATIONAHA.105.571315","article-title":"Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury","volume":"112","author":"Wang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0385","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1073\/pnas.95.17.10134","article-title":"A mAb to the beta2-leukocyte integrin Mac-1 (CD11b\/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits","volume":"95","author":"Rogers","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0390","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1440-1797.2005.00438.x","article-title":"Partial depletion of macrophages by ED7 reduces renal injury in adriamycin nephropathy","volume":"10","author":"Wang","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0395","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2249.1995.tb08363.x","article-title":"Anti-CD11b\/CD18 antibodies reduce inflammation in acute colitis in rats","volume":"101","author":"Palmen","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0400","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jlb.46.6.556","article-title":"Heterogeneity of macrophages in the rat evidenced by variability in determinants: two new anti-rat macrophage antibodies against a heterodimer of 160 and 95 kd (CD11\/CD18)","volume":"46","author":"Damoiseaux","year":"1989","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0405","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/eji.1830230321","article-title":"Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats","volume":"23","author":"Huitinga","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0410","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.CIR.0000019581.22812.B2","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors: recognition of a two-edged sword?","volume":"106","author":"Quinn","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0415","doi-asserted-by":"crossref","first-page":"12942","DOI":"10.1021\/bi026324c","article-title":"Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen","volume":"41","author":"Lishko","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0420","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/153537020422901104","article-title":"Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo","volume":"229","author":"Flick","year":"2004","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbagen.2013.02.018_bb0425","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI20741","article-title":"Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2\/Mac-1 is critical for host inflammatory response in vivo","volume":"113","author":"Flick","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0430","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/emboj.2011.333","article-title":"Regulation of integrin affinity on cell surfaces","volume":"30","author":"Schurpf","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0435","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1073\/pnas.0911378107","article-title":"Inhibition of Mac-1 (CD11b\/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.018_bb0440","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0969-2126(01)00271-4","article-title":"Two conformations of the integrin A-domain (I-domain): a pathway for activation?","volume":"3","author":"Lee","year":"1995","journal-title":"Structure"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651300069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651300069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T19:38:37Z","timestamp":1688067517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651300069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S030441651300069X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.02.018","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule agonists of integrin CD11b\/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}